NASDAQ:KZR - Kezar Life Sciences, Inc.
$19.23
 $-0.77
-3.85%
4:00PM EDT
2019-04-18
Kezar Life Sciences, Inc., incorporated on February 19, 2015, is a clinical-stage biopharmaceutical company. The Company is engaged in developing novel small molecule therapeutics to treat autoimmune disorders and cancer. Its therapies target protein homeostasis. Its lead development program is KZR-616. KZR-616 is a selective small molecule inhibitor of the immunoproteasome. Its second program focuses on small-molecule modulators of the protein secretion pathway. Its protein secretion program is focused on the areas of oncology, inflammation and immune-oncology. KZR-616s indications include Lupus nephritis, Idiopathic inflammatory myopathies, autoimmune hemolytic anemia, multiple sclerosis, and crohns disease among others.The Company competes with GlaxoSmithKline, AstraZeneca, Janssen Biotech, Inc, Eli Lilly and Co, Celgene, and Aurinia Pharmaceuticals, Inc Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KZR     avg for
industry  
  avg for
sector  
42 stocks weight:  13. 77   199. 07   233. 87  
42 stocks rank:  2. 94 K 1. 43 K 1. 06 K
# analyst opinions:  2. 00   14. 48   14. 09  

quick ratio:  32. 20   5. 29   1. 92  
current ratio:  32. 91   5. 64   2. 40  

target price low:  29. 00   84. 50   115. 74  
target price avg:  29. 50   110. 73   137. 39  
target price high:  30. 00   136. 41   157. 80  
1-yr high:  32. 90   114. 11   138. 85  
last close:  19. 23   87. 56   116. 78  
50-day avg:  19. 35   95. 43   123. 53  
200-day avg:  20. 53   94. 13   121. 20  
1-yr low:  15. 50   72. 67   98. 41  
volume:  29. 11 K 2. 43 M 4. 85 M
50-day avg volume:  102. 06 K 2. 72 M 4. 97 M
200-day avg volume:  66. 96 K 2. 90 M 4. 58 M

1-day return:  -3. 85 % -0. 40 % 0. 07 %
this week return:  -4. 57 % -5. 72 % -4. 11 %
12-wk return:  -0. 05 % 1. 78 % -0. 04 %
52-wk return:  10. 81 % 14. 09 %

enterprise value (EV):  273. 79 M 51. 19 B 117. 96 B
market cap:  367. 62 M 43. 00 B 104. 52 B
EBITDA:  -24. 04 M 4. 45 B 8. 01 B
enterprise multiple (EV/EBITDA):  -11. 39   4. 34   13. 27  
total debt:  0. 00   12. 22 B 16. 66 B
net income (common):  -23. 17 M 2. 20 B 4. 21 B

shares outstanding:  19. 12 M 570. 91 M 1. 24 B
shares:  10. 47 M 571. 02 M 1. 23 B
shares short:  876. 04 K 9. 93 M 16. 79 M
shares short prior month:  732. 13 K 9. 96 M 16. 58 M
short ratio:  5. 59   5. 31   3. 30  
short % of float:  5. 87 % 5. 81 % 2. 61 %
total cash/share:  5. 62   11. 13   9. 30  
total cash:  107. 43 M 6. 70 B 7. 10 B
free cash flow:  -13. 12 M 3. 58 B 4. 74 B
operating cash flow:  -20. 79 M 4. 14 B 6. 32 B

book value:  5. 69   12. 76   26. 84  
price/book:  3. 38   3. 08   -1. 74  
operating margins:  0. 00 % -721. 97 % -88. 82 %
EBITDA margins:  0. 00 % 10. 94 % 22. 54 %
profit margins:  0. 00 % 7. 81 % 10. 60 %
gross margins:  0. 00 % 37. 02 % 55. 68 %

1-yr max volatility:  -24. 32 % --- ---
1-yr mean volatility:  0. 10 % 0. 03 % 0. 04 %

1-yr EPS:  -2. 26   2. 39   4. 08  
forward EPS:  -2. 16   3. 97   7. 14  
P/E:  -8. 52   13. 59   22. 83  
forward P/E:  -9. 33   -20. 05   14. 49  
PE/G:  1. 41   -1. 46   1. 68  
growth:  -6. 04 % 126. 81 % 29. 29 %
earnings high:  -0. 32   1. 02   1. 63  
earnings avg:  -0. 40   0. 76   1. 51  
earnings low:  -0. 52   0. 47   1. 39  
revenue high:  -0. 00   2. 68 B 10. 71 B
revenue avg:  -0. 00   2. 59 B 10. 49 B
revenue low:  -0. 00   2. 49 B 10. 25 B
return on assets:  -18. 30 % -2. 80 % 5. 29 %
return on equity:  -28. 77 % -18. 52 % 7. 38 %

beta (1yr vs S&P500):  0. 82   1. 24   0. 93  
sharpe (1yr):  0. 44   0. 29   0. 60  

held % insiders:  24. 72 % 6. 38 % 3. 38 %
held % institutions:  49. 86 % 78. 60 % 68. 65 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-19 : KZR
.    + 2.128 =         2.128 :: INITIAL WEIGHT
.   + 86.047 =        88.175 :: inverse volume-to-price addition
.      + 1.0 =        89.175 :: spline projection addition
.    x 4.873 =       434.525 :: 13 weeks' performance factor
.    x 1.083 =       470.756 :: one-year gains+dividend factor
.    x 1.432 =       674.134 :: industry recommendation factor
.    x 0.998 =       672.901 :: return on assets factor
.    x 0.997 =       670.965 :: return on equity factor
.      x 5.1 =      3422.178 :: current ratio factor
.    x 1.016 =      3476.595 :: quick ratio factor
.    x 1.086 =      3774.774 :: short ratio factor
.    x 2.034 =      7677.076 :: price-to-book factor
.    x 1.033 =      7932.251 :: 5-day avg > 50-day avg
.    x 2.014 =     15973.924 :: P/E weight
.    x 0.918 =     14657.621 :: PE/G factor
.    x 1.523 =      22317.03 :: beta factor
.    x 0.435 =      9709.458 :: sharpe factor
.    x 1.766 =     17145.863 :: target low factor
.    x 1.244 =     21322.567 :: target mean factor
.    x 1.075 =      22918.29 :: target high factor
.    x 1.312 =     30060.739 :: industry 2-weeks return factor
.    x 0.932 =     28031.563 :: "drift" penalty 5 days ago
.    x 0.992 =     27800.964 :: overall "drift" factor
.    x 0.999 =     27767.987 :: largest single-day jump factor
.     x 1.01 =     28045.391 :: mean volatility factor
.    x 1.098 =     30784.746 :: 42-day mean volatility factor
.      x 1.0 =     30779.783 :: factor hist industry gain for week 15
.   cubeRoot =        31.339 :: reduced to standardize
.   - 17.567 =        13.772 :: add/subtract for performance
.                     13.772 :: FINAL WEIGHT for NASDAQ:KZR


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org